This research was undertaken to explore whether incorporating Lactobacillus reuteri into the conventional triple therapy enhances the elimination success and clinical and pathological outcomes of Helicobacter pylori infection, given the decreasing effectiveness of the standard triple therapy in eradicating H. pylori.

Link to: Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients

Our first product Gut Rebuild not only includes L. reuteri but is optimized for the creation of reuterin